1[1]Bertrand OF,Sipehia R,Mongrain R,et al.Biocompatibility aspects of new stent technology[J].J Am Coll Cardiol,1998;32:562
2[2]Hehrlein C,Zimmerman M,Metz J,et al.Influence of surface texture and charge on the biocompatibility of endovascular stents[J].Coronary Artery Dis,1995;6:581
3[3]Van der Giessen W,Lincoff A,Schwartz R,et al.Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries[J].Circulation,1996;94:1690
4[4]Malik N,Gun J,shepherd L,et al.Phosphorylcholine-coated stents in porcine coronary arteries:angiographic and morphometric assessment [abstract][J].Eur Heart J,1997;18:152
5[5]Harder C,Rzany A,Schaldach M.Coating of vascular stents with antithrombogenic amorphous silicon carbide[J].Progr Biomed Res,1999;4:71
6[6]Lincoff A,Furst J,Ellis S,et al. Sustained local delivery of dexamethasone by a novel intravascular eluting stent to prevent restenosis in the porcine coronary injury model[J].J Am Coll Cardiol,1997;29:808
7[7]Topol EJ,Serruys PW.Frontiers in interventional cardiology.Circulation,1998;98:1802
8[8]Mckenna CJ,Camrud AR,Wolff R et al. Evaluation of the biocompatibility and safety of fibrin-film stenting up to one year post deployment in a porcine coronary injury model [abstract][J].Am J Cardiol,1997;80(supp17A):155
9[9]Bonan R,Bhatk,Lefvere T,et al.Coronary artery stenting after angioplasty with self-expanding parallel wire metallic stents[J].Am Heart J,1991;121:1522
10[10]Serruys P,Emanuelesson H,Van der Giessen W,et al.Heparin-coated Palmaz-Schatz stents in human coronary arteries:early outcome of the Benestent-Ⅱ pilot study[J].Circulation,1996;93:412
同被引文献6
1北京医学院.生物化学[M].北京：人民卫生出版社,1982..
2Whelan D M, Van Der Giessen W J, Krabbendam S C et al. Bio-compatibility of phosphoryl-choline coated stents in normal porcine coronary arteries [ J ]. Heart, 2000,83 ( 3 ) :338-345.
